IGM Biosciences Statistics Share Statistics IGM Biosciences has 61.98M
shares outstanding. The number of shares has increased by 1.34%
in one year.
Shares Outstanding 61.98M Shares Change (YoY) 1.34% Shares Change (QoQ) 0.57% Owned by Institutions (%) 29.13% Shares Floating 29.88M Failed to Deliver (FTD) Shares 24 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 404.56K, so 0.67% of the outstanding
shares have been sold short.
Short Interest 404.56K Short % of Shares Out 0.67% Short % of Float 2.07% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -1.89 and the forward
PE ratio is -0.91.
IGM Biosciences's PEG ratio is
0.06.
PE Ratio -1.89 Forward PE -0.91 PS Ratio 138.02 Forward PS 5.9 PB Ratio 7.68 P/FCF Ratio -2.33 PEG Ratio 0.06
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for IGM Biosciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.14,
with a Debt / Equity ratio of 0.94.
Current Ratio 5.14 Quick Ratio 5.14 Debt / Equity 0.94 Debt / EBITDA -0.23 Debt / FCF -0.28 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $17.98K Profits Per Employee $-1.31M Employee Count 149 Asset Turnover 0.01 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -85.5% in the
last 52 weeks. The beta is 0.59, so IGM Biosciences's
price volatility has been higher than the market average.
Beta 0.59 52-Week Price Change -85.5% 50-Day Moving Average 1.27 200-Day Moving Average 3.88 Relative Strength Index (RSI) 48.26 Average Volume (20 Days) 608,650
Income Statement In the last 12 months, IGM Biosciences had revenue of 2.68M
and earned -195.79M
in profits. Earnings per share was -3.24.
Revenue 2.68M Gross Profit -6.43M Operating Income -208.58M Net Income -195.79M EBITDA -199.47M EBIT -208.58M Earnings Per Share (EPS) -3.24
Full Income Statement Balance Sheet The company has 26.5M in cash and 45.19M in
debt, giving a net cash position of -18.69M.
Cash & Cash Equivalents 26.5M Total Debt 45.19M Net Cash -18.69M Retained Earnings -1.02B Total Assets 106.99M Working Capital 100.93M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -153M
and capital expenditures -5.85M, giving a free cash flow of -158.85M.
Operating Cash Flow -153M Capital Expenditures -5.85M Free Cash Flow -158.85M FCF Per Share -2.62
Full Cash Flow Statement Margins Gross margin is -240.13%, with operating and profit margins of -7785.74% and -7308.51%.
Gross Margin -240.13% Operating Margin -7785.74% Pretax Margin -7308.51% Profit Margin -7308.51% EBITDA Margin -7445.61% EBIT Margin -7785.74% FCF Margin -5929.38%
